COCP vs UDR · rev $105.0K vs P/E 26, rev $1.71B
Cocrystal Pharma Inc (COCP) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
COCP currently screens at market cap $13.3M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the COCP and UDR stock pages for the full models.
Not investment advice.